Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis

FEMS Microbiology Letters

Volumn 262, Issue 2, 2006, Pages 210-215

  Pardini, Manuela ^a   Giannoni, Federico ^a   Palma, Carla ^a   Iona, Elisabetta ^a   Cafaro, Aurelio ^a   Brunori, Lara ^a   Rinaldi, Monica ^b   Fazio, Vito Michele ^c   Laguardia, Maria Elena ^d   Carbonella, Damiano Cosimo ^d   Magnani, Mauro ^d   Ensoli, Barbara ^a   Fattorini, Lanfranco ^a   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNR   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d UNIVERSITY OF URBINO   (Italy)

Author keywords

85B antigen; DNA vaccines; HIV Tat; Immune responses; Mice protection; Tuberculosis

Indexed keywords

ANTIGEN; BCG VACCINE; DNA VACCINE; MESSENGER RNA; PLASMID DNA; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; FIBROBLAST; GENE CASSETTE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; MOLECULAR WEIGHT; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUBERCULOSIS;

ACYLTRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GENE PRODUCTS, TAT; GENES, TAT; HIV-1; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NIH 3T3 CELLS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSFECTION; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, DNA;

ANIMALIA; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 33747655832     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2006.00390.x     Document Type: Article

References (24)

1. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ & Besra GS (1997) Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276: 1420-1422.
2. Britton WJ & Palendira U (2003) Improving vaccines against tuberculosis. Immunol Cell Biol 81: 34-45.
3. Ciafre SA, Rinaldi M, Vespignani I, Parrella P, Seripa D, Signori E, Ria F, Farace MG & Fazio VM (1998) A plasmid family containing two different expression cassettes suitable for immunomodulation and genetic immunization. Plasmid 40: 84-89.
4. Delogu G, Li A, Repique C, Collins F & Morris SL (2002) DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis. Infect Immun 70: 292-302.
5. Doherty TM & Andersen P (2005) Vaccines for tuberculosis: novel concepts and recent progress. Clin Microbiol Rev 18: 687-702.
6. Doherty TM, Olsen AW, Weischenfeldt J et al. (2004) Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J Infect Dis 190: 2146-2153.
7. Ensoli B, Cafaro A, Caputo A, Fiorelli V, Ensoli F, Gavioli R, Ferrantelli F, Cara A, Titti F & Magnani M (2005) Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant DeltaV2 Env. Microbes Infect 7: 1392-1399.
8. Fanales-Belasio E, Moretti S, Nappi F, Barillari G, Micheletti F, Cafaro A & Ensoli B (2002) Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. J Immunol 168: 197-206.
9. Feng CG, Palendira U, Demangel C, Spratt JM, Malin AS & Britton WJ (2001) Priming by DNA immunization augments protective efficacy of Mycobacterium bovis bacille Calmette-Guerin against tuberculosis. Infect Immun 69: 4174-4176.
10. Ferrantelli F, Cafaro A & Ensoli B (2004) Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines. Curr Opin Biotechnol 15: 543-556.
11. Gavioli R, Gallerani E, Fortini C et al. (2004) HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. J Immunol 173: 3838-3843.
12. Hesseling AC, Schaaf HS, Hanekom WA, Beyers N, Cotton MF, Gie RP, Marais BJ, van Helden P & Warren RM (2003) Danish bacille Calmette-Guerin vaccine-induced disease in human immunodeficiency virus-infected children. Clin Infect Dis 37: 1226-1233.
13. Huygen K (2005) Plasmid DNA vaccination. Microbes Infect 7: 932-938.
14. Kamath AT, Feng CG, Macdonald M, Briscoe H & Britton WJ (1999) Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 67: 1702-1707.
15. Kamath AT, Fruth U, Brennan MJ et al. AERAS Global TB Vaccine Foundation; World Health Organization (2005). New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development. Vaccine 23: 3753-3756.
16. Kaufmann SH & McMichael AJ (2005) Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 11: S33-S44.
17. Marinaro M, Riccomi A, Rappuoli R, Pizza M, Fiorelli V, Tripiciano A, Cafaro A, Ensoli B & De Magistris MT (2003) Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA. Vaccine 21: 3972-3981.
18. Olsen AW, Hansen PR, Holm A & Andersen P (2000) Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 30: 1724-1732.
19. Palendira U, Kamath AT, Feng CG, Martin E, Chaplin PJ, Triccas JA & Britton WJ (2002) Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis. Infect Immun 70: 1949-1956.
20. Papa S, Rinaldi M, Mangia A, Parrella P, Signori E, Lombardi L & Fazio VM (1998) Development of a multigenic plasmid vector for HCV DNA immunization. Res Virol 149: 315-319.
21. Ramakrishna L, Anand KK, Mohankumar KM & Ranga U (2004) Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization. J Virol 78: 9174-9189.
22. Romano M, Roupie V, Hamard M & Huygen K (2006) Evaluation of the immunogenicity of pBudCE4.1 plasmids encoding mycolyl-transferase Ag85A and phosphate transport receptor PstS-3 from Mycobacterium tuberculosis. Vaccine 24: 4640-4643.
23. Rook GA, Dheda K & Zumla A (2005) Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat Rev Immunol 5: 661-667.
24. Tanghe A, D'Souza S, Rosseels V, Denis O, Ottenhoff TH, Dalemans W, Wheeler C & Huygen K (2001) Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun 69: 3041-3047.